Published online before print September 6, 2007

This Article Full Text (Rapid PDF) All Versions of this Article: ajpath.2007.070520v1 171/4/1312    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Barrachina, M. Articles by Ferrer, I. Search for Related Content PubMed PubMed Citation Articles by Barrachina, M. Articles by Ferrer, I.

Copyright © 2007 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2007.070520

Accepted for publication July 13, 2007.

Article

Target Genes of Neuron-Restrictive Silencer Factor Are Abnormally Up-Regulated in Human Myotilinopathy

Marta Barrachina^*, Jesús Moreno^*, Salvador Juvés^*, Dolores Moreno^*, Montse Olivé^*, and Isidre Ferrer^*@

From the Institut de Neuropatologia,* Servei Anatomia Patològica, Instituto de Investigacion de Bellvitge-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat; and the Unitat de Neuropatologia Experimental, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona, Hospitalet de Llobregat, Llobregat, Spain

^@ To whom correspondence should be addressed. E-mail: 8082ifa{at}comb.es.

	Abstract

Myotilinopathy is a subgroup of myofibrillar myopathies caused by mutations in the myotilin gene in which there is aggregation of abnormal cytoskeletal proteins and ubiquitin. We report here on the accumulation of neuron-related proteins such as ubiquitin carboxy-terminal hydrolase L1 (UCHL1), synaptosomal-associated protein 25, synaptophysin, and -internexin in aberrant protein aggregates in myotilinopathy. We have determined that the neuron-restrictive silencer factor (NRSF)/RE1 silencing transcription factor (REST), a transcription factor expressed in non-neuronal tissues repressing the expression of several neuronal genes, is reduced in myotilinopathies. Moreover, NRSF transfection reduces UCHL1, synaptosomal-associated protein 25, synaptophysin, and -internexin mRNA levels in DMS53 cells, whereas short interferring NRSF transfection increases UCHL1 and synaptophysin mRNA levels in U87-MG cells. Chromatin immunoprecipitation assays have shown that NRSF interacts with the UCHL1 promoter in U87-MG and HeLa cells. In silico analysis of the UCHL1 gene promoter sequence using the MatInspector software has predicted three potential neuron-restrictive silencer elements (NRSEs): NRSE1 located in the complementary DNA chain and NRSE2 and NRSE3 in intron 1, in the coding and complementary chains, respectively. Together, these findings show, for the first time, abnormal regulation of NRSF/REST as a mechanism associated with the aberrant expression of selected neuron-related proteins, which in turn accumulate in abnormal protein aggregates, in myotilinopathy.